Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 975Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 13ESPERION THERAPS INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BEMPEDOIC ACID

US Patent Number : 11744816

Drug Substance Claim :

Drug Product Claim :

Application Number : 211616

Patent Use Code : U-3883

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-14

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BEMPEDOIC ACID; EZETIMIBE

US Patent Number : 11744816

Drug Substance Claim :

Drug Product Claim :

Application Number : 211617

Patent Use Code : U-3883

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-14

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BEMPEDOIC ACID; EZETIMIBE

US Patent Number : 10912751

Drug Substance Claim :

Drug Product Claim :

Application Number : 211617

Patent Use Code : U-3884

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-14

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BEMPEDOIC ACID; EZETIMIBE

US Patent Number : 11926584

Drug Substance Claim :

Drug Product Claim :

Application Number : 211617

Patent Use Code : U-3873

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-06-19

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BEMPEDOIC ACID

US Patent Number : 11926584

Drug Substance Claim :

Drug Product Claim :

Application Number : 211616

Patent Use Code : U-3873

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-06-19

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BEMPEDOIC ACID; EZETIMIBE

US Patent Number : 11744816

Drug Substance Claim :

Drug Product Claim :

Application Number : 211617

Patent Use Code : U-3692

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-14

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BEMPEDOIC ACID; EZETIMIBE

US Patent Number : 10912751

Drug Substance Claim :

Drug Product Claim :

Application Number : 211617

Patent Use Code : U-3224

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-03-14

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BEMPEDOIC ACID; EZETIMIBE

US Patent Number : 11613511

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 211617

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-06-19

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BEMPEDOIC ACID; EZETIMIBE

US Patent Number : 11760714

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211617

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-06-19

blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

BEMPEDOIC ACID

US Patent Number : 11760714

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211616

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2040-06-19

blank